Apple Therapeutics Private Limited, a active private limited company, was established on 29 July 2004 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232DL2004PTC127958. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Protech Therapeutics Private Limited. It upholds a compliant status. Employing 142 professional, Its leadership includes Asheesh Srivastava (Director), Sanjeev Tomar (Director). Past directors included Uday Shanker Choudhary, Prem Khanna, Sanjeev Tomar. It holds ₹2.49 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 506, 507 & 507A, Fifth Floor Hemkunt Tower, 98 Nehru Place, Delhi, Delhi, 110019.
U24232DL2004PTC127958
127958
29 July 2004
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Apple Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asheesh Srivastava | Director | 04 Aug 2005 | Current |
| Sanjeev Tomar | Director | 21 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Nov 2014 | Past |
| Pramod Abcsdd | Director | 11 Dec 2007 | Past |
| Pramod Abcsdd | Additional Director | 28 Aug 2015 | Past |
| Pramod Abcsdd | Director | 29 Nov 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apple Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.8% increase. The company also saw a substantial fall in profitability, with a 17.19% decrease in profit. The company's net worth Soared by an impressive increase of 16.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Apple Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,485,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2020 | Others | ₹2.49 M | Open |
Explore comprehensive loan charge details -
Apple Therapeutics has a workforce of 142 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apple Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apple Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Apple Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Apple Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others amounted to Rs. 2.49 M with Charge ID 100345437 was registered on 09 Mar 2020. was recorded as a recent event.
The activity Sanjeev Tomar was appointed as a Director was appointed as a Director on 21 Nov 2014 & has been associated with this company since 11 years 1 month . was completed.
The activity Asheesh Srivastava was appointed as a Director was appointed as a Director on 04 Aug 2005 & has been associated with this company since 20 years 4 months . was completed.
Apple Therapeutics Private Limited was registered on 29 Jul 2004 with Roc Delhi & aged 21 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Apple Therapeutics Private Limited is U24232DL2004PTC127958.
Apple Therapeutics Private Limited is headquartered at 506, 507 & 507A, Fifth Floor Hemkunt Tower, 98 Nehru Place, Delhi, Delhi, 110019.
Apple Therapeutics Private Limited was incorporated on 29 July 2004.
The current directors of Apple Therapeutics Private Limited are
The primary industry of Apple Therapeutics Private Limited is Trade.
Apple Therapeutics Private Limited is unlisted.
The authorized capital of Apple Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Apple Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX